Nothing Special   »   [go: up one dir, main page]

NO159448C - Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin.

Info

Publication number
NO159448C
NO159448C NO822801A NO822801A NO159448C NO 159448 C NO159448 C NO 159448C NO 822801 A NO822801 A NO 822801A NO 822801 A NO822801 A NO 822801A NO 159448 C NO159448 C NO 159448C
Authority
NO
Norway
Prior art keywords
methyl
methylendioxybenzyl
ethenediamine
furanyl
dimethylamino
Prior art date
Application number
NO822801A
Other languages
English (en)
Norwegian (no)
Other versions
NO159448B (no
NO822801L (no
Inventor
Leonard De Vincentiis
Original Assignee
Ausonia Farma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11208027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO159448(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ausonia Farma Srl filed Critical Ausonia Farma Srl
Publication of NO822801L publication Critical patent/NO822801L/no
Publication of NO159448B publication Critical patent/NO159448B/no
Publication of NO159448C publication Critical patent/NO159448C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO822801A 1981-08-18 1982-08-17 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin. NO159448C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23546/81A IT1168163B (it) 1981-08-18 1981-08-18 Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative

Publications (3)

Publication Number Publication Date
NO822801L NO822801L (no) 1983-02-21
NO159448B NO159448B (no) 1988-09-19
NO159448C true NO159448C (no) 1988-12-28

Family

ID=11208027

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822801A NO159448C (no) 1981-08-18 1982-08-17 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin.

Country Status (23)

Country Link
US (1) US4431664A (it)
JP (1) JPS5859982A (it)
KR (1) KR860000851B1 (it)
AR (1) AR230444A1 (it)
AT (1) AT383597B (it)
AU (1) AU533719B2 (it)
BE (1) BE894093A (it)
CA (1) CA1182121A (it)
CH (1) CH650259A5 (it)
DE (1) DE3230265C2 (it)
DK (1) DK156067C (it)
ES (1) ES8306372A1 (it)
FR (1) FR2511675A1 (it)
GB (1) GB2104071B (it)
GR (1) GR76260B (it)
IT (1) IT1168163B (it)
LU (1) LU84340A1 (it)
NL (1) NL186447C (it)
NO (1) NO159448C (it)
PH (1) PH19228A (it)
PT (1) PT75440B (it)
SE (1) SE448456B (it)
ZA (1) ZA825718B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1175808B (it) * 1984-03-07 1987-07-15 Ausonia Farma Srl Procedimento per la preparazione di composto con attivita' antiulcera
IT1196133B (it) * 1984-06-06 1988-11-10 Ausonia Farma Srl Derivati furanici con attivita' antiulcera
KR950009825B1 (ko) * 1986-03-28 1995-08-29 자누스 화마스티씨 에스.알.엘. 치료학적 항궤양 활성이 있는 니페로티딘의 합성방법
HU9203905D0 (en) * 1989-04-05 1993-04-28 Glaxo Group Ltd Method for producing ranitidine
JPH0416036U (it) * 1990-05-31 1992-02-10

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140681A (en) * 1974-11-08 1979-02-20 Mitsubishi Chemical Industries, Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IT8123546A0 (it) 1981-08-18
PT75440A (en) 1982-09-01
BE894093A (nl) 1982-12-01
AT383597B (de) 1987-07-27
NO159448B (no) 1988-09-19
NL186447B (nl) 1990-07-02
JPS5859982A (ja) 1983-04-09
GB2104071A (en) 1983-03-02
CA1182121A (en) 1985-02-05
NO822801L (no) 1983-02-21
ES515068A0 (es) 1983-06-01
FR2511675A1 (fr) 1983-02-25
DK156067B (da) 1989-06-19
DE3230265A1 (de) 1983-03-03
AU533719B2 (en) 1983-12-08
DK357182A (da) 1983-02-19
GB2104071B (en) 1985-03-27
KR860000851B1 (ko) 1986-07-09
SE448456B (sv) 1987-02-23
SE8204670L (sv) 1983-02-19
SE8204670D0 (sv) 1982-08-12
DK156067C (da) 1989-12-04
LU84340A1 (fr) 1983-02-28
CH650259A5 (it) 1985-07-15
US4431664A (en) 1984-02-14
NL186447C (nl) 1990-12-03
ATA312282A (de) 1986-12-15
NL8203160A (nl) 1983-03-16
AU8673182A (en) 1983-02-24
JPS6335631B2 (it) 1988-07-15
FR2511675B1 (it) 1984-02-10
ES8306372A1 (es) 1983-06-01
PH19228A (en) 1986-02-12
ZA825718B (en) 1983-06-29
KR840001162A (ko) 1984-03-28
GR76260B (it) 1984-08-04
PT75440B (en) 1986-02-04
AR230444A1 (es) 1984-04-30
DE3230265C2 (de) 1984-09-20
IT1168163B (it) 1987-05-20

Similar Documents

Publication Publication Date Title
NL190757C (nl) 4-(3-Chloorfenyl)-1-piperazinylpropyl gesubstitueerde-1,2,4-triazool-3-on verbindingen met antidepressieve werking en farmaceutische preparaten daarvan.
NO158419C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
NO851949L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO157102C (no) AnalogifremgangsmŸte til fremstilling av terapeutisk aktivt 3-(2-morfolinoetylamino)-5-fenylpyridazin.
NO154268C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere.
NO159448C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
ES513576A0 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.
AR230275A1 (es) Un procedimiento para la preparacion de n-(2-((5-dimetilamino)metil-2-furanilmetil)tio)etil)-n'-metil-2-nitro-1 1-etenodiamina(ranitidina)
NZ191699A (en) N-(1-methyl-2-pyrrolidinyl methyl)-2,3-dimethoxy-5-methyl-sulphamoyl benzamide derivatives pharmaceutical compositions
IT1167794B (it) Procedimento per la preparazione del n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1 etendiamina
AR225940A1 (es) Un procedimiento para preparar la n-(2-((5-(dimetilamino)metil)-2-furanilmetil)tio)etil)-n'-metil-2-nitro-1,1-etenodiamina
NO153848C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(arylthioalkyl)-n[-(aminoalkyl)-ureaderivater.
ES497386A0 (es) Procedimiento para la obtencion de la n-(2-( ( (5-( (dimeti-lamino)metil)-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1-etenodiamina
ES497737A0 (es) Procedimiento para la obtencion de la n-(2-((5-((dimetilami-no)metil)furfuril)tio)etil)-n'- metil -2- nitro-1,1- eteno- diamina
IT1149947B (it) Procedimento di preparazione della n-(2-(((5-(dimetilamino)-metil-2-flranil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etilendiamina
IT1167489B (it) Procedimento per la preparazione della n-(2-(((5-(dimetilamino)-metil-2-furil)-metil)-tio)-)n'-metil-2-nitro-1,1-etilendiamina
DK157494C (da) Fremgangsmaade til fremstilling af n-(2(((5-((dimethylamino)-methyl)-2-furanyl)methyl)thio)ethyl)-n'(3,4-methylendioxybenzyl)-2-nitro-1,1-ethendiamin
ES543966A0 (es) Procedimiento para la preparacion de la n-(2-(((5-(dimetila-mino)-metil-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1- etendiamina
ES544063A0 (es) Procedimiento para la preparacion de la n-(2-(((5-(dimetila-mino)metil-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1- etilendiamina
ES504463A0 (es) Procedimiento para la obtencion de la n-(2-(((5-(dimetilami-no)metil)-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1- etenodiamina
ES523235A0 (es) "procedimiento para la preparacion de n-(2-(((5-(dimetilamino)-metil-2-furanil) metil) tio) etil) -n'- metil-2-nitro 1,1-etenodiamina"
IT1169237B (it) Metodo per l'isolamento e la purificazione della n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etendiamina
ES544062A0 (es) Procedimiento para la obtencion de la n-(2-(((5-(dimetilami-no)metil-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1- etilendiamina